dialysis drugs(tesis drugs)
TRANSCRIPT
-
8/20/2019 Dialysis Drugs(tesis drugs)
1/22
NAME
OF
DRUG
MECHANIS
M OF
ACTION
CLASSIFICA
TION
DOSAGE INDICATION CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
BRAND
NAME:Ferrogr
ad fol!
GENERI
C
NAME:
Ferro"#
S"lfa$e
% Fol!
a!d
Ferro"##"l&'a$e I$(or)#*+re&la!,g ro,, +o"r*od+ f +o"r
*od+doe#,o$&rod"!ee,o"g'o, $#o(,
Fol!
a!d'el+o"r*od+&rod"!e a,d.a,$a, ,e(!ell#/
A,$a,e
.!
011
.g 211
.gO,e
$a*
&er
da+
Trea$,g
a,e.a
!a"#ed
*+ lo(
le3el# of
ro, or
fola$e ,
$'e
*lood I$
re&la!e#
ro, ,
$'e *od+
('e, $'e
*od+
doe# ,o$
&rod"!e
e,o"g'
o, $#o(,
Co,$ra,
d!a$ed
,
&a$e,$#
('o
'a3e
e4&ere,
!ed ($'
&aro4+#
.al,o!$"r,a
l
'e.oglo
*,"ra
5'e.ogl
o*, ,
$'e
"r,e/
e#&e!all+
o*#er3e
d , $'e
.or,,g
a# dar)
!olored
"r,e6/
GI:
d#!o.f
or$/
'ear$
*"r,/
lo## of
a&&e$$e
/
,a"#ea/
3o.$,g/
!o,#$&a
$o,/
darr'ea
S$ool
dar)e,
,g or
*lood+
#$ool.a+
o!!"r
Ad3#e &a$e,$
$o $a)e ferro"#
f".ara$e7fol!
a!d ($' a f"ll
gla## of (a$er
Do ,o$ le do(,
for 81 .,"$e#
af$er $a),g
ferro"#
f".ara$e7fol!a!d
Ta)e ferro"#
f".ara$e a,d
fol! a!d o, a,
e.&$+
#$o.a!'/ a$
lea#$ 9 'o"r
*efore or 0'o"r# af$er a
.eal
If +o" .## a
do#e of ferro"#
f".ara$e7fol!
a!d/ $a)e $ a#
-
8/20/2019 Dialysis Drugs(tesis drugs)
2/22
a,dal#o'el
&re3e,$!'a,ge# $oDNA$'a$.a+lead $o!a,!er
a!!"."l
a$o, of
ro,/ a,d
e4!e##
ro, ,
$'e *od+
#oo, a#
&o##*le If $ #
al.o#$ $.e for
+o"r ,e4$ do#e/
#)& $'e .##ed
do#e a,d go
*a!) $o +o"r
reg"lar do#,g
#!'ed"le Do
,o$ $a)e 0
do#e# a$ o,!e
Tell $'e &a$e,$
$'a$ Ferro"#f".ara$e7fol!
a!d .a+ !a"#e
dar)e,ed or
gree, #$ool#
T'# # ,or.al
a,d ,o$ a !a"#e
for !o,!er,
Do NOT $a)e.ore $'a, $'e
re!o..e,ded
do#e ($'o"$
!'e!),g ($'
+o"r do!$or
-
8/20/2019 Dialysis Drugs(tesis drugs)
3/22
-
8/20/2019 Dialysis Drugs(tesis drugs)
4/22
NAME
OF
DRUG
MECHANIS
M OF
ACTION
CLASSIFIC
A -TION
DOSAGE INDICATION CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
BRAND
NAME:.o$ll"
.
GENERI
C
NAME:
Do.&er
do,e
Do.&er
do,e a!$#a# a
ga#$ro,$
e#$,al
e.&$+,g
5dela+ed6
ad",!$
a,d
&er#$al$
!#$."la,$
Do.&er
do,e
fa!l$a$e#
ga#$r!
e.&$+,g
a,d
de!rea#e
# #.all*o(el
$ra,#$
$.e *+
,!rea#,
g
e#o&'age
al a,d
A,$do
&a.,e
rg! A,$e.
e$!
91 "g
o,e
$a* 8
$.e#
a da+
For
.a,age
.e,$ of
d+#&e
a/
'ear$*"r,
/
e&ga#$r!
&a,/
,a"#ea/a,d
3o.$,g
Co,$ra,
d!a$ed
,
&a$e,$#
($'
),o(,
#e,#$3$
+
or ,$oler
a,!e $o$'e dr"g
ra#'
I$!',g 'eada!'
e dr+
.o"$' d;;,e#
# ,er3o"#
,e##
rr$a*l$
+ leg
!ra.
A##e## for e4$ra-
&+ra.dal e
-
8/20/2019 Dialysis Drugs(tesis drugs)
5/22
ga#$r!
&er#$al#
# a,d *+
lo(er,g
e#o&'ageal
#&',!$er
&re##"re
-
8/20/2019 Dialysis Drugs(tesis drugs)
6/22
NAME
OF
DRUG
MECHANISM
OF ACTION
CLASSIFICATI
ONDOSAGE INDICATION CONTRAINDI
CA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
BRAND
NAME:Co;aar
Ar*lo!
GENER
IC
NAME:
Lo#ar$
a,
Lo#ar$a,
5.ore#&e!=!all
+/ $'e
!'e.!al
for.ed
('e,
$'e l3er !
o,3er$#
$'e
,a!$3elo#ar$a,
,$o $#
a!$3e
for.6
*lo!)#
$'e
a,go$e,#
,
re!e&$or
B+*lo!),g
$'e
a!$o, of
a,go$e,#
,/
lo#ar$a,
rela4e#
A,go$e
,#, II
re!e&$or
*lo!)er
911.
g $a*
o,!e a
da+
Trea$.e
,$ of
da*e$!
,e&'ro&
a$'+ ,
$+&e 0
da*e$e#
($'
'+&er$e,
#o,
Co,$ra,d
!a$ed ,
&a$e,$
('o are
da*e$!
a,d
$a),g al
#)re,
U&&er
Re#&ra$
or+
Tra!$
I,fe!$o
, D;;,e#
# I,#o.,
a M"#!le
Cra. Leg Pa,
H+&er)a
le.a A,goed
e.a Or$'o#$
a$!
H+&o$e,
#o,
A##e##&a$e,$#
re,al f",!$o,
Ad.,#$er
($'o"$ regard
$o .eal#
Mo,$or &a$e,$#
BP
Mo,$or
&a$e,$# ('o
are al#o $a),g
d"re$!#
for #+.&$o.a$
!
'+&o$e,#o,
Tell &a$e,$ $oa3od
#al$ #"*#$$"$e
#
Mo,$or
&a$e,$ !lo#el+
, a,+
-
8/20/2019 Dialysis Drugs(tesis drugs)
7/22
."#!le
!ell# a,d
dla$e#
*lood
3e##el#$'ere*+
red"!,g
*lood
&re##"re
#$"a$o, $'a$
.a+ lead $o a
de!rea#e ,
*lood &re##"re#e!o,dar+ $o
red"!$o, ,
>"d 3ol".e
e4!e##3e
&er#&ra$o,/
de'+dra$o,/
3o.$,g/ a,d
darr'ea
e4!e##3e
'+&o$e,#o,
!a, o!!"r
NAME
OF
DRUG
MECHANISM
OF ACTION
CLASSIFI
CA-TION
DOSAGE INDICATION CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
-
8/20/2019 Dialysis Drugs(tesis drugs)
8/22
BRAND
NAME:
Nor3a#!
A.3a#!
BE
GENERI
C NAME:
A.lod&
,e
I,'*$#
$'e
.o3e.e,
$ of
!al!".
o,#
a!ro## $'e
.e.*ra,
e# of
!arda!
a,d
ar$eral
."#!le!ell#?
,'*$# $r
a,#.e.*
ra,e !al!
". >o(/
('!'
re#"l$# ,
$'e
de&re##o, of
.&"l#e
for.a$o,
,
#&e!al;e
d !arda!
&a!e.a)e
Cal!"
.
!'a,,
el-
*lo!)
er A,$a
,g,al
dr"g A,$'
+&er$
e,#3
e
I,$all
+/
2 .g
PO
dal+ Do#a
ge
.a+
*e
grad"
all+
,!rea
#edo3er
91@9
da+#
$o a
.a4
.".
do#e
of
91 .g PO
dal+
A,g,a
&e!$or#
d"e $o
!oro,ar+
ar$er+
#&a#. C'ro,!
#$a*le
a,g,a/
alo,e or
,
!o.*,a$
o, ($'o$'er
age,$# E##e,$al
'+&er$e,
#o,/
alo,e or
,
!o.*,a$
o, ($'o$'er a,$
'+&er$e,
#3e#
Co,$ra,
d!a$ed
($'
allerg+
$o a.lod
&,e/
.&ared
'e&a$!
or re,al
f",!$o,/
#!)
#,"#
#+,dro.e/ 'ear$
*lo!)
5#e!o,d
or $'rd
degree6/
a,d
la!$a$o,
U#e!a"$o"#l
+ ($'
CHF/
®,a,
!+
CNS:
D;;,e#
#/ lg'$-
'eaded
,e##/
'eada!'
e/ a#$'e
,a/ fa$
g"e/
le$'arg+
CV:
Per&'er
al
ede.a/
arr'+$'
.a
Dermat
ologic:Fl"#',g
/ ra#'
GI: Na"
#ea/ a*d
o.,al
d#!o.f
or$
Mo,$or
&a$e,$
!aref"ll+ 5BP/
a,d o"$&"$6('le
ad"#$,g
dr"g $o
$'era&e"$!
do#e
Mo,$or
!arda!
r'+$'.
reg"larl+
d"r,g
#$a*l;a$o,
of do#age
a,d
&erod!all+
d"r,g lo,g-
$er. $'era&+
Ad.,#$er
dr"g ($'o"$
regard $o
.eal# *"$
$a)e ($'
.eal# f
-
8/20/2019 Dialysis Drugs(tesis drugs)
9/22
r !ell#/
#lo(,g of
$'e
3elo!$+ of
!o,d"!$o
, of $'e
!arda!
.&"l#e/
de&re##o
, of
.+o!arda
l
!o,$ra!$l$+/ a,d
dla$o, of
!oro,ar+
ar$ere#
a,d
ar$erole#
a,d
&er&'eral
ar$erole#?$'e#e
e
-
8/20/2019 Dialysis Drugs(tesis drugs)
10/22
!arda!
o4+ge,
!o,#".&$
o,/ a,d ,
&a$e,$#
($' 3a#o#
&a#$! 5Pr
,;.e$al#6
a,g,a/
,!rea#ed
del3er+ of
o4+ge, $o
!arda!
!ell#
#'or$,e## of
*rea$'/
#(ell,g of
$'e 'a,d# orfee$/
d;;,e##/
a,d
!o,#$&a$o,
-
8/20/2019 Dialysis Drugs(tesis drugs)
11/22
NAME
OF
DRUG
MECHANIS
M OF
ACTION
CLASSIFICA
TION
DOSAGE INDICATION CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
BRAND
NAME:E&oge,
Pro!r$
GENERI
C
NAME:
E&oe$,
Alfa
M.!#
$'ee
-
8/20/2019 Dialysis Drugs(tesis drugs)
12/22
o, Se;"re# ",der#$a,d,
g o$'er#
#&ee!'
Mo,$or f
feel# #"dde,
$ro"*le ,
(al),g/
d;;,e##/ lo##
of *ala,!e or
!oord,a$o,
Mo,$or BP
*efore $'e
$'era&+
NAME
OF
DRUG
MECHANIS
M OF
ACTION
CLASSIFICA
TION
DOSAGE INDICATION CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
-
8/20/2019 Dialysis Drugs(tesis drugs)
13/22
BRAND
NAME:
Ne4".
GENERI
C
NAME:
E#o.e&
ra;ole
Red"!e
#
ga#$r!
a!d
#e!re$
o, a,d
de!rea
#e#
ga#$r!
a!d$+
Pro$o,
P".&
I,'*$or
#
1g
o1,e
!a&
o,!e a
da+
Ga#$roe#
o&'ageal
re>"4
d#ea#e
5GERD6 To red"!e
r#) of
ga#$r!
"l!er ,
&a$e,$#
re!e3,g
!o,$,"o
"#
NSAIDS
$'era&+ To
el.,a$e
H &+lor
Co,$ra,
d!a$ed
,
&a$e,$
($'
'e&a$!
,#"!e
,!+ a,d
,
®,a,$
a,d
la!$a$,g
.o$'er
CNS:
'eada!'
e
GI:
A*do.,al &a,/
!o,#$&a
$o,/
darr'ea
/ dr+
.o"$'/
>a$"le,
!e/
,a"#ea/
3o.$,
g
G3e dr"g a$
lea#$ 9 'o"r
*efore .eal#
If 3a NGT
o&e, !a"le
a,d e.&$+ $'e
gra,"le# ,$o a
1 .l #+r,ge
Mo,$or
&a$e,$# for
ra#' or #g,#
a,d #+.&$o.#
of
'+&er#e,#$3$
+
Mo,$or l3er
f",!$o, $e#$
I,#$r"!$
&a$e,$ $o $a)edr"g e4a!$l+
a# &re#!r*e
Ad3#e &a$e,$
$'a$ a,$a!d#
!a, *e "#ed
('le $a),g
-
8/20/2019 Dialysis Drugs(tesis drugs)
14/22
dr"g ",le##
o$'er(#e
dre!$ed *+
&re#!r*er
ar. $'e
&a$e,$ ,o$ $o
!'e( or !r"#$
&elle$ *e!a"#e
$'# !a,
,a!$3a$e $'e
dr"g#
NAME
OF
DRUG
MECHANIS
M OF
ACTION
CLASSIFICATI
ON
DOSAGE INDICATIO
N
CONTRAINDI
CA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
-
8/20/2019 Dialysis Drugs(tesis drugs)
15/22
BRAND
NAME:
Cal$ra$e
11
O#-Cal
211
T".#
E4$ra
T".#
C'e(+
delg'$
GENERI
C
NAME:
Cal!".
Car*o,a
$e
Red"!e
# $o$ala!dload ,
GI$ra!$/ele3a$e#ga#$r!&H $ored"!e&e,a!$3$+/
#$re,g$'e,#ga#$r!."!o#al*arrer/ a,d,!rea#e#e#o&'a
geal#&',!$er$o,e
Cal!".
Sal$
211
.g
$a*
$'ree
$.e#
a da+
A!d
,dge#$
o,/
!al!".
#"&&le
.e,$
Co,$ra,d
!a$ed $o
&a$e,$#
($'
,!rea#ed
!al!".
le3el ,
*lood
a,d7or
,!rea#ed
!al!". ,
"r,e/
)d,e+
#$o,e/
,!rea#ed
le3el of
3$a., D/
a,d
&'o#&'a$e
, *lood
CNS:
Heada!
'e/
rr$a*l$
+/(ea),e
##
GI:
Na"#ea/
!o,#$&a
$o,/
>a$"le,
!e/
re*o",d
'+&era!
d$+
A##e## for
,a"#ea a,d
3o.$,g/
a,ore4a/$'r#$/
#e3ere
!o,#$&a$o,
A##e# for
'ear$*"r,/
,dge#$o,/
a*do.,al
&a,
Mo,$or VS
e#&e!all+ BP
a,d PR
Mo,$or
#er".
!al!".*efore
$rea$.e,$
Re!ord
a.o",$ a,d
!o,##$e,!+
of #$ool
-
8/20/2019 Dialysis Drugs(tesis drugs)
16/22
a$!' for
e3de,!e of
'+&er)ale.a
NAME
OF
MECHANIS
M OF
CLASSIFICATI
ON
DOSAGE INDICATION CONTRAINDI
CA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
-
8/20/2019 Dialysis Drugs(tesis drugs)
17/22
DRUG ACTION
BRAND
NAME:
Ca$a&re
#Ca$a&r
e-TTS
e,loga
GENERI
C NAME:
Clo,d,
e
U,),o(
,
T'o"g'$
$o#$."la$
e al&'a
re!er$or
a,d
,'*$
$'e
!e,$ral
3a#o.o
$or!e,$er#/
de!rea#
,g
#+.&'a
$$!
o"$>o(
$o $'e
'ear$/
)d,e+/
a,d
&er&'e
ral
3a#!"la$
"re a,d
lo(er,
g
&er&'e
Ce,$rall+
a!$,g
al&'a
ago,#$
2.!g7
$a*
o,!e a
da+
E##e,$al
a,d re,al
'+&er$e,#
o, Se3ere
!a,!er
&a, D+#.e,or
r'ea
Co,$ra,d
!a$ed $o
&a$e,$#
($'#e3ere
!oro,ar+
,#"!e
,!+/
!o,d"!$o
,
d#$"r*a,
!e/ re!e,$
MI/!ere*ro3a
#!"lar
d#ea#e/
CRF/ or
.&ared
l3er
f",!$o,
CNS:Dro(#,e
##/
d;;,e##/
#eda$o,/
(ea),e#
#/
fa$g"e/
ag$a$o,
/
de&re##
o, CV:
Brad+!ar
da/
or$'o#$a$
!
'+&o$e,#
o,
GI:
Co,#$&a
$o,/ dr+.o"$'/
a,ore4a GU:
Ur,e
re$e,$o,
/
.&o$e,!
e
O*#er3e
&a$e,$ $o
$olera,!e $'edr"g#
$'era&e"$!
e
-
8/20/2019 Dialysis Drugs(tesis drugs)
18/22
ral
3a#!"la
r
re##$a,
!e/ BPa,d HR
Skin:
Pr"r$"#/
ra#'
I,for. &a$e,$
$'a$ d;;,e##
"&o, #$a,d,g
!a, *e.,.;ed *+
r#,g #lo(l+
fro. #$$,g or
l+,g &o#$o,
Ad3#e &a$e,$
$o a3od
#"dde,
&o#$o,
!'a,ge#
NAME
OF
MECHANIS
M OF
CLASSIFICATI
ON
DOSAGE INDICATION CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
-
8/20/2019 Dialysis Drugs(tesis drugs)
19/22
DRUG ACTION
BRAND
NAME:
A$"r,,
GENERI
C
NAME:
A$or3a#
$a$,
HMG-
CoA
red"!$
a#e
,'*$o
r?
,'*$#
ra$e-
l.$,g
#$e& ,
!'ole#$
erol*o#+,$
'e##
*+
!o.&e
$$3el+
,'*$
,g
HMG-
CoAred"!$
a#e
HMG-
CoA
red"!$a#
e
,'*$or
91.g7
$a*
o,e
$a*
7da+
Ad",!$
$o de$ ,
&r.ar+
'+&er!'ol
e#$erole
.a
5'e$ero;+
go"#
fa.lal
a,d
,o,fa.l
al6 a,d.4ed
d+#l&de
.a
5T+&e# IIa
a,d II*6
$o red"!e
$o$al-C/
LDL-C/
a&o Ba,d TG/
a,d $o
,!rea#e
HDL-C To red"!e
r#) of MI/
Co,$ra,
d!a$ed
,
&a$e,$#
($'
#e3ere
l3er
&ro*le.
#/ ('o
are
$a),g
HIV&ro$ea#e
,'*$or
#/ d"r,g
®,a,
!+ a,d
*rea#$fe
ed,g/
a,d
'+&er#e,#$3$+
CNS:
Heada!
'e/
,#o.a
CV:
Per&'er
al
ede.a
GI:
A*do.
,al
&a, /
!o,#$&a
$o,/
,a"#ea
GU:
UTI RESPIR
ATORY:*ro,!'$
#
Skin:ra#'
Tea!' &a$e,$
a*o"$ &ro&er
de$ar+
.a,age.e,$
/ (eg'$
!o,$rol/ a,d
e4er!#e
ar. &a$e,$
$o a3od
al!o'ol
Tell &a$e,$ $o
,for.
&re#!r*er of
ad3er#e
rea!$o, #"!'
a# fe3er
Ad3#e&a$e,$ $'a$
dr"g !a, *e
$a)e, a$ a,+
$.e of da+/
($'o"$
regard $o
.eal#
-
8/20/2019 Dialysis Drugs(tesis drugs)
20/22
S$ro)e
a,d
a,g,a
NAME
OF
MECHANIS
M OF
CLASSIFICA
TION
DOSAGE INDICATION CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
-
8/20/2019 Dialysis Drugs(tesis drugs)
21/22
DRUG ACTION
BRAND
NAME:
Le3a"
,
GENERI
C
NAME:
Le3o>o
4a!,
I,'*$#
*a!$er
al? DNA
g+ra#e
a,d
&re3e,
$ DNA
re&l!a$
o,/
$ra,#!r
&$o,/
r$e&ar/ a,d
re!o.
*,a$o
, ,
#"#!e&
$*le
*a!$er
a
Flo"ro"
,olo,e
211.
g7 $a*O,e
$a*
OD
$.e#
da+#
A!"$e
*a!$eral
#,"#$#
!a"#ed
*+
S$r&$o!o!
"#
P,e".o,
ae Co..",
$+
a!"re#&,e".o,
a fro. S
P,e".o,
ae A!"$e
&el3!
,>a..a
$or+
Mld $o.odra$e
UTI
Co,$ra,
d!a$ed
,
&a$e,$
($'
'+&er#e
,#$3$+
$o dr"g
CNS:
Se;"re/
d;;,e#
#/
'eada!'
e/
,#o.,
a CV:
C'e#$
&a,/
&al&$a$
o,# GI:
A*do.
,al &a,/
!o,#$&a
$o,/
darr'ea
/
>a$"le,!e REPIRAT
ORY:Allerg!
&,e".o
,$# SIN:
Mo,$or
gl"!o#e le3el
a,d re,al/
'e&a$! a,d
'e.a$o&oe$!
*lood #$"de#
Tell $o &a$e,$
$o $a)e dr"# a#
&re#!r*e/
e3e, f #g,#
a,d #+.&$o.#d#a&&ear
Ad3#e &a$e,$
$o $a)e dr"g
($' &le,$+ of
>"d#
ar, &a$e,$
$o a3od
'a;ardo"#
a!$3$e#
Ad3#e $'e
&a$e,$ $o
a3od
e4!e##3e
#",lg'$ a,d
-
8/20/2019 Dialysis Drugs(tesis drugs)
22/22
P'o$o#e
,#$3o$+
/
&r"r$"#/
ra#'
(ear
&ro$e!$3e
!lo$',g ('e,
o"$ door#
I,#$r"!$ $'e
&a$e,$ $o
,o$f+
&re#!r*er of
loo#e #$ool or
darr'ea